Despite the use of effective drug and device therapies, many patients with HFrEF continue to experience worsening symptoms and disease progression. Barostim is a novel device therapy that works with drug therapies to target the neurohormonal pathways responsible for heart failure progression and symptoms. Patients feel better and their quality of life improves.